Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:104-110
Published online before print October 17, 2002, doi: 10.1161/01.ATV.0000042232.42883.56
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/1/104    most recent
01.ATV.0000042232.42883.56v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shamir, R.
Right arrow Articles by Hayek, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shamir, R.
Right arrow Articles by Hayek, T.
Related Collections
Right arrow Animal models of human disease
Right arrow Other arteriosclerosis
Right arrow Other diabetes
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:104.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Oral Insulin Supplementation Attenuates Atherosclerosis Progression in Apolipoprotein E-Deficient Mice

Raanan Shamir; Naim Shehadeh; Mira Rosenblat; Orly Eshach-Adiv; Raymond Coleman; Marielle Kaplan; Shadi Hamoud; Sophie Lischinsky; Tony Hayek

From the Pediatric Gastroenterology and Nutrition Unit (R.S., O.E.A.) and Juvenile Diabetes Unit (N.S.), Meyer Children’s Hospital of Haifa; Department of Medicine E (S.H., T.H.) and Department of Biochemistry (S.L.), Rambam Medical Center; and Lipid Research Laboratory (M.R., M.K., T.H.) and Department of Anatomy and Cell Biology (R.C.), Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Correspondence to Raanan Shamir, MD, Division of Pediatric Gastroenterology and Nutrition, Meyer Children’s Hospital of Haifa, Rambam Medical Center, POB 9602, Haifa 31096, Israel. E-mail shamirr{at}netvision.net.il

Objective— The role of insulin in atherosclerosis progression in diabetes is uncertain. We examined the effects of oral insulin supplementation on atherogenesis in apolipoprotein E-deficient (E0) mice.

Methods and Results— One-month-old male E0 mice were orally supplemented with human insulin (0.1, 0.5, and 1 U/mL) or placebo for 3 months. At the end of the study, serum and macrophage oxidative stress and atherosclerosis progression were studied. Insulin reduced lesion size by 22% to 37% (P<0.05) in all study groups. Lipid peroxides serum levels were 18% lower (P<0.01), and serum paraoxonase activity was 30% higher (P<0.01) in mice supplemented with 1.0 U/mL insulin compared with controls. Insulin reduced mouse peritoneal macrophage (MPM) lipid peroxides content and superoxide anion release by up to 44% and 62%, respectively (P<0.01). In addition, oral insulin reduced MPM cholesterol content and cholesterol biosynthesis by up to 36% and 53%, respectively (P<0.01). In vitro incubation of E0 mice MPM with increasing insulin concentrations (0 to 100 µU/mL) resulted in a dose-dependent reduction of cholesterol synthesis by up to 66% (P<0.05).

Conclusions— In E0 mice, oral insulin supplementation attenuates the atherosclerotic process. This may be attributable to insulin-mediated reduction of oxidative stress in serum and macrophages as well as reduction in macrophage cholesterol content.


Key Words: oral insulin • atherosclerosis • oxidative stress • paraoxonase • macrophages




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. M. Breen, K. K. Chan, J. K. Dhaliwall, M. R. Ward, N. Al Koudsi, L. Lam, M. De Souza, H. Ghanim, P. Dandona, D. J. Stewart, et al.
Insulin Increases Reendothelialization and Inhibits Cell Migration and Neointimal Growth After Arterial Injury
Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 1060 - 1066.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Dandona, A. Chaudhuri, H. Ghanim, and P. Mohanty
Insulin as an anti-inflammatory and antiatherogenic modulator.
J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S14 - S20.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Mayr, Y.-L. Chung, U. Mayr, X. Yin, L. Ly, H. Troy, S. Fredericks, Y. Hu, J. R. Griffiths, and Q. Xu
Proteomic and Metabolomic Analyses of Atherosclerotic Vessels From Apolipoprotein E-Deficient Mice Reveal Alterations in Inflammation, Oxidative Stress, and Energy Metabolism
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2135 - 2142.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg
Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation
Circulation, March 22, 2005; 111(11): 1448 - 1454.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Dandona, A. Chaudhuri, and A. Aljada
The Relationship of Fasting Serum Radioimmune Insulin Levels to Incident Coronary Heart Disease in an Insulin-Treated Diabetic Cohort
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5868 - 5869.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. S. Meir and E. Leitersdorf
Atherosclerosis in the Apolipoprotein E-Deficient Mouse: A Decade of Progress
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1006 - 1014.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Chaudhuri, D. Janicke, M. F. Wilson, D. Tripathy, R. Garg, A. Bandyopadhyay, J. Calieri, D. Hoffmeyer, T. Syed, H. Ghanim, et al.
Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment-Elevation Myocardial Infarction
Circulation, February 24, 2004; 109(7): 849 - 854.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Urakawa, A. Katsuki, Y. Sumida, E. C. Gabazza, S. Murashima, K. Morioka, N. Maruyama, N. Kitagawa, T. Tanaka, Y. Hori, et al.
Oxidative Stress Is Associated with Adiposity and Insulin Resistance in Men
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4673 - 4676.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
P. Dandona, A. Aljada, and A. Bandyopadhyay
Hyperglycemia After Myocardial Infarction: Response to Dhatariya
Diabetes Care, July 1, 2003; 26(7): 2222 - 2223.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Dandona, A. Aljada, A. Chaudhuri, and A. Bandyopadhyay
The Potential Influence of Inflammation and Insulin Resistance on the Pathogenesis and Treatment of Atherosclerosis-Related Complications in Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2422 - 2429.
[Full Text] [PDF]